180 related articles for article (PubMed ID: 25792823)
1. Peptide gH625 enters into neuron and astrocyte cell lines and crosses the blood-brain barrier in rats.
Valiante S; Falanga A; Cigliano L; Iachetta G; Busiello RA; La Marca V; Galdiero M; Lombardi A; Galdiero S
Int J Nanomedicine; 2015; 10():1885-98. PubMed ID: 25792823
[TBL] [Abstract][Full Text] [Related]
2. Enhanced uptake of gH625 by blood brain barrier compared to liver in vivo: characterization of the mechanism by an in vitro model and implications for delivery.
Falanga A; Iachetta G; Lombardi L; Perillo E; Lombardi A; Morelli G; Valiante S; Galdiero S
Sci Rep; 2018 Sep; 8(1):13836. PubMed ID: 30218088
[TBL] [Abstract][Full Text] [Related]
3. gH625-liposomes as tool for pituitary adenylate cyclase-activating polypeptide brain delivery.
Iachetta G; Falanga A; Molino Y; Masse M; Jabès F; Mechioukhi Y; Laforgia V; Khrestchatisky M; Galdiero S; Valiante S
Sci Rep; 2019 Jun; 9(1):9183. PubMed ID: 31235716
[TBL] [Abstract][Full Text] [Related]
4. Shuttle-mediated nanoparticle delivery to the blood-brain barrier.
Guarnieri D; Falanga A; Muscetti O; Tarallo R; Fusco S; Galdiero M; Galdiero S; Netti PA
Small; 2013 Mar; 9(6):853-62. PubMed ID: 23135878
[TBL] [Abstract][Full Text] [Related]
5. Clickable functionalization of liposomes with the gH625 peptide from Herpes simplex virus type I for intracellular drug delivery.
Tarallo R; Accardo A; Falanga A; Guarnieri D; Vitiello G; Netti P; D'Errico G; Morelli G; Galdiero S
Chemistry; 2011 Nov; 17(45):12659-68. PubMed ID: 21956538
[TBL] [Abstract][Full Text] [Related]
6. gH625 is a viral derived peptide for effective delivery of intrinsically disordered proteins.
Smaldone G; Falanga A; Capasso D; Guarnieri D; Correale S; Galdiero M; Netti PA; Zollo M; Galdiero S; Di Gaetano S; Pedone E
Int J Nanomedicine; 2013; 8():2555-65. PubMed ID: 23901273
[TBL] [Abstract][Full Text] [Related]
7.
Galdiero E; Falanga A; Siciliano A; Maselli V; Guida M; Carotenuto R; Tussellino M; Lombardi L; Benvenuto G; Galdiero S
Int J Nanomedicine; 2017; 12():2717-2731. PubMed ID: 28435254
[TBL] [Abstract][Full Text] [Related]
8. Shuttle-mediated nanoparticle transport across an in vitro brain endothelium under flow conditions.
Falanga AP; Pitingolo G; Celentano M; Cosentino A; Melone P; Vecchione R; Guarnieri D; Netti PA
Biotechnol Bioeng; 2017 May; 114(5):1087-1095. PubMed ID: 27861732
[TBL] [Abstract][Full Text] [Related]
9. Liposome armed with herpes virus-derived gH625 peptide to overcome doxorubicin resistance in lung adenocarcinoma cell lines.
Perillo E; Porto S; Falanga A; Zappavigna S; Stiuso P; Tirino V; Desiderio V; Papaccio G; Galdiero M; Giordano A; Galdiero S; Caraglia M
Oncotarget; 2016 Jan; 7(4):4077-92. PubMed ID: 26554306
[TBL] [Abstract][Full Text] [Related]
10. Elucidation of the interaction mechanism with liposomes of gH625-peptide functionalized dendrimers.
Falanga A; Tarallo R; Carberry T; Galdiero M; Weck M; Galdiero S
PLoS One; 2014; 9(11):e112128. PubMed ID: 25423477
[TBL] [Abstract][Full Text] [Related]
11. Quantitative and qualitative effect of gH625 on the nanoliposome-mediated delivery of mitoxantrone anticancer drug to HeLa cells.
Perillo E; Allard-Vannier E; Falanga A; Stiuso P; Vitiello MT; Galdiero M; Galdiero S; Chourpa I
Int J Pharm; 2015 Jul; 488(1-2):59-66. PubMed ID: 25891256
[TBL] [Abstract][Full Text] [Related]
12. Chemically synthesized peptide libraries as a new source of BBB shuttles. Use of mass spectrometry for peptide identification.
Guixer B; Arroyo X; Belda I; Sabidó E; Teixidó M; Giralt E
J Pept Sci; 2016 Sep; 22(9):577-91. PubMed ID: 27440580
[TBL] [Abstract][Full Text] [Related]
13. N-methyl phenylalanine-rich peptides as highly versatile blood-brain barrier shuttles.
Malakoutikhah M; Prades R; Teixidó M; Giralt E
J Med Chem; 2010 Mar; 53(6):2354-63. PubMed ID: 20170117
[TBL] [Abstract][Full Text] [Related]
14. Nanomedicine as a non-invasive strategy for drug delivery across the blood brain barrier.
Tam VH; Sosa C; Liu R; Yao N; Priestley RD
Int J Pharm; 2016 Dec; 515(1-2):331-342. PubMed ID: 27769885
[TBL] [Abstract][Full Text] [Related]
15. gH625: a milestone in understanding the many roles of membranotropic peptides.
Galdiero S; Falanga A; Morelli G; Galdiero M
Biochim Biophys Acta; 2015 Jan; 1848(1 Pt A):16-25. PubMed ID: 25305339
[TBL] [Abstract][Full Text] [Related]
16. Drug delivery to the CNS and polymeric nanoparticulate carriers.
Costantino L
Future Med Chem; 2010 Nov; 2(11):1681-701. PubMed ID: 21428839
[TBL] [Abstract][Full Text] [Related]
17. Structure and orientation of the gH625-644 membrane interacting region of herpes simplex virus type 1 in a membrane mimetic system.
Galdiero S; Russo L; Falanga A; Cantisani M; Vitiello M; Fattorusso R; Malgieri G; Galdiero M; Isernia C
Biochemistry; 2012 Apr; 51(14):3121-8. PubMed ID: 22397737
[TBL] [Abstract][Full Text] [Related]
18. Dimerization in tailoring uptake efficacy of the HSV-1 derived membranotropic peptide gH625.
Falanga A; Valiante S; Galdiero E; Franci G; Scudiero O; Morelli G; Galdiero S
Sci Rep; 2017 Aug; 7(1):9434. PubMed ID: 28842580
[TBL] [Abstract][Full Text] [Related]
19. Nanofiber-based delivery of therapeutic peptides to the brain.
Mazza M; Notman R; Anwar J; Rodger A; Hicks M; Parkinson G; McCarthy D; Daviter T; Moger J; Garrett N; Mead T; Briggs M; Schätzlein AG; Uchegbu IF
ACS Nano; 2013 Feb; 7(2):1016-26. PubMed ID: 23289352
[TBL] [Abstract][Full Text] [Related]
20. Re-engineering biopharmaceuticals for delivery to brain with molecular Trojan horses.
Pardridge WM
Bioconjug Chem; 2008 Jul; 19(7):1327-38. PubMed ID: 18547095
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
